Please try another search
For the fiscal year ended 31 December 2021, 4d Pharma PLC revenues decreased 2% to £522K. Net loss increased from £26M to £54M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other Non Rec I/E - Non Business Activ increase from £0K to £44.4M (expense), Other administrative costs increase of 66% to £2.2M (expense).
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0.198 | 0.16 | 0.16 | |
Gross Profit | 0.198 | 0.16 | 0.16 | |
Operating Income | -9.28 | -9.12 | -9.12 | |
Net Income | -3.5 | -12.46 | -12.46 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 58.79 | 58.79 | 66.46 | 66.46 |
Total Liabilities | 26.38 | 26.38 | 26.8 | 26.8 |
Total Equity | 32.42 | 32.42 | 39.65 | 39.65 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -8.74 | -10.22 | -10.22 | |
Cash From Investing Activities | -0.059 | -0.08 | -0.08 | |
Cash From Financing Activities | 5.02 | 18.19 | 18.19 | |
Net Change in Cash | -3.83 | 8.32 | 8.32 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review